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Abstract
Background: Despite dramatic improvements in the management of burns, infection still remains
a serious risk for the burn patient. The aim of this study was to shed light on the impact of acute
burn injury with or without infection on cytokine profiles.
Methods: Sprague-Dawley rats (n = 21) were randomized into three groups: 1) burn only 2) burn
and infection or 3) sham burn. Weight was monitored and blood was collected for cytokine ELISA,
LPS quantification, and peripheral blood analysis. Animals were sacrificed either after 6 or 12 days.
Results: Infected animals showed substantial weight loss until day 6 post-burn as compared to
burn alone. Endotoxin and TNF-α levels were elevated early in the infected burn group within 48
hours post-burn. In contrast, significant up-regulation of the anti-inflammatory cytokine IL-10
occurred later in the clinical course and was associated with the recovery from weight loss.
Conclusion: Our results suggest that in the presence of infection, you get a SIRS response possibly
due to transient endotoxemia that is only seen in the infection group. In contrast, both burn and
infection get a late IL-10 (CARS) response, which is then associated with a return to normal weight
in the infection group.
Background
While current procedures for burn injury management
have improved patient prognosis, increased morbidity
and mortality remains a major challenge for the clinician.
Thus, identification of the mechanisms responsible for
post-burn immune dysfunction and increased susceptibil-
ity to wound infection, subsequent sepsis and multiple
organ failure under such conditions, is crucial for the
development of improved treatment modalities. Thermal
injury induces an immuncompromised state that
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[1-6]. Skin, as the first line of defense against invading
microbes, is equipped with an array of immune mediators
capable of recruiting inflammatory cells to enable neutral-
ization and clearance of bacteria and fungi [7,8]. Hence,
immune failure in a burn patient who has lost the skin
barrier is vulnerable to infection. These are major compli-
cations associated with burn trauma and recent evidence
suggests that activation of a pro-inflammatory cascade
plays an important role in their development [9].
For a long time the integument had been considered as an
organ of passive protection but over the past few years sev-
eral discoveries have shown that the skin is not only the
target of diseases connected with immunological mecha-
nisms but moreover, an important immunocompetent
organ in itself [10]. The difficulty depends on the causal
connectivity of findings since a clear distinction has not
always been made between the early shock phase and the
later continuance of organ failure. Various physiologic
and immunologic alterations are observed in acute
inflammations associated with infection, trauma and
thermal injury. Recently, increasing attention has been
directed to the role of cytokines in the mechanisms of
such alterations. Tumor necrosis factor-α (TNF-α), inter-
leukin-1β (IL-1β), interleukin-6 (IL-6), which are pro-
inflammatory cytokines, and interleukin-10 (IL-10) are
considered potential mediators of inflammation pro-
duced by immunoregulatory cells as well as by a variety of
other cell types [11]. Cytokines play a major role in the
regulation of immune response, hematopoesis and
inflammation [12].
The aim of this paper is to shed light on the role of wound
infection with Pseudomonas aeruginosa on the systemic
inflammatory response and weight loss in burn injury.
Methods
Bacteria
A multi drug resistant strain of Pseudomonas aeruginosa iso-
lated from human burn wound was used for this study.
Over night culture was diluted into fresh TSB and incu-
bated for 2.5 h at 37°C. The subculture was centrifuged
(10 min, 4°C, 880 g). The bacterial pellet was washed
once and resuspended in a cold sodium phosphate buffer
(J.T.Baker, Deventer, Holland, pH 7.4). CFU were calcu-
lated by OD600 nm measurement (UV-VIS-Spektrometer,
Perkin Elmer 555).
Animals
Adult male Sprague-Dawley rats (250–300 g) were
obtained from the Unit for Laboratory Animal Medicine
(University of Michigan, Ann Arbor, MI) and maintained
under standard laboratory conditions. In addition to a
resting period at the institutional vivarium, animals were
acclimated to the laboratory environment for at least 48
hours before treatment. After treatment, the rats were
placed in individual cages in a temperature controlled
room with food and water provided ad libitum and a 12
hour light and a 12 hour dark diurnal cycle. All experi-
ments were performed in accordance with National Insti-
tute of Health guidelines and approval was obtained from
the University of Michigan Animal Care and Use
Committee.
Experimental design
Sprague-Dawley rats (n = 21) were randomized into three
groups: 1) burn only; 2) burn and infection (108 CFU of
multi-drug resistant Pseudomonas aeruginosa) or 3) sham
burn. Animals in the first two groups received a 30%
(TBSA) partial thickness burn. The animals were anesthe-
tized prior to each intervention with intraperitoneal Keta-
mine hydrochloride (100 mg/kg; Fort Dodge
Laboratories, Fort Dodge, Iowa) and Xylazine (13 mg/kg;
Bayer Corporation, Shawnee Mission, Kansas) injection.
The skin of the whole torso was clipped and treated with
depilatory cream (Sally Hansen®Div. Del Laboratories,
Inc., Farmingdale. NY). Twenty-four hours later, rats were
placed in a mold, which exposed an area of 30% total
body surface area (TBSA). Rats, except the sham burn
group 3, sustained a superficial partial scald injury at the
defined area on both flanks and back at 60°C for twenty
seconds. This extend of injury in this animal model is time
dependent and has been previously described [13]. Addi-
tionally, the burn wound of the infected group was cov-
ered with a 2 cm × 2 cm gauze containing 108 CFU
(colony forming units) of log-phase Pseudomonas aerugi-
nosa. Injury was covered with Tegaderm™ HP (3 M Health
Care, St. Paul, MN) and Flex-Wrap™ Self-Adherent Wrap
(The Kendall Company, Mansfield, MA). After treatment,
rats were resuscitated subcutaneously with 5 ml saline. For
the remainder of the study, all animals received buprenor-
phine (0.3 mg/kg) intra peritoneal twice daily for pain
control post-burn. In previous experiments we have not
observed any abdominal injury with this scald burn
model which could affect food intake or absorption [13-
17]. Weight changes were monitored daily. Blood was col-
lected after 12, 24, 48 and 72 h, then after 6 and 12 days.
This was used for cytokine ELISA, LPS quantification, and
peripheral blood analysis. After either 6 or 12 days the
animals were sacrificed and treated areas of the infected
and non infected wound tissues were harvested asepti-
cally, weighed, homogenized, serially diluted and plated
in triplicate on trypticase soy agar with 5% sheep blood
and Pseudomonas isolation agar (both from Becton Dick-
inson). Bacterial plates were then incubated for 18 hours
and the number of colony forming units were counted in
blinded fashion. Results are expressed as CFU per gram
infected skin tissue.Page 2 of 7
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At appropriate time points, 20 µl of EDTA anti-coagulated
blood was collected from the rat tail vein. A Hemavet Mas-
cot Multispecies Hematology System Counter 1500 R
(CDC Technologies Inc., Oxford, CT) was used to meas-
ure the blood differential, WBC, RBC, hemoglobin and
hematocrit. Furthermore, 200 µl of plasma was collected
and stored at -20°C for cytokine and endotoxin screening.
Endotoxin levels
For the purpose of determining the amount of endotoxin
present in the plasma, a QCL-1000 Limulus Amebocyte
Lysate Assay (Bio Whittaker Inc., Walkersville, MD) was
performed. This assay uses a modified Limulus Amebo-
cyte Lysate and a coloring substrate to detect gram-nega-
tive bacterial endotoxin chromogenically. Following the
manufacturer's instruction, 50 µl of plasma was diluted
1:10 in order to quantify the endotoxin levels. Concentra-
tions were photospectrometrically analyzed at 410 nm
and calculated corresponding to the standard curve.
Cytokines
With the purpose of quantifying changes in cytokine lev-
els, ELISA's were performed for IL-1β, IL-6, Il-10 and TNF-
α using Cytoscreen™ Immunoassay Kits (BioSource Inter-
national, Inc., Camarillo, CA). Following the manufac-
turer's instruction, 50 µl of plasma was used in a 1:1
dilution. ELISA plates were read on a plate reader (Bio-Tek
Instruments, Windoski, VT) at dual wavelengths of 465
nm and 590 nm. Sample concentrations were determined
by comparison to a standard curve.
Statistical analysis
Data with normal distribution was analyzed using
ANOVA and Student's t-test (StatView®, Abacus Concepts/
SAS® Institute, Cary, N.C.). Results were considered to be
significant at p < 0.05 and expressed as the mean ± SEM.
Results
Wound infection
Macroscopic evaluation of burned skin immediately after
the scald injury revealed notable paleness. A few minutes
later a reddish pink coloration appeared, giving way to
progressive pallor over the next 30–60 minutes. Edema
reached a peak after approximately 2 hours and then
slowly regressed, disappearing completely during the
ensuing 24 hours. At the day of sacrifice, the infected
wounds showed clear signs of macroscopic wound infec-
tion with pus and redness in the inoculated and adjacent
tissue. Tissue counts in the infected group showed 106-107
CFU of P. aeruginosa per gram of tissue compared to 101-
102 CFU in the non infected groups. Throughout the study
period no mortalities in any of the groups was observed.
Weight changes
Weight loss is a prominent metabolic response to thermal
injury and infection. As shown in figure 1, weight loss was
significant higher for 6 days postoperatively in the
infected burn group compared to the other treatment
groups. In the infected group, weight decreases constantly
until day 6 (mean difference day 1–6: 38.820 g). In this
period the weight loss shows significance (p < 0.05) com-
pared to the control group at every time point. Although
the infected burn group recovers from the first weight loss
and regained weight after 7 days postoperatively, weight
remains significantly lower than in the control group. No
significant difference in weight loss was observed compar-
ing the sham burn groups with the burn only group. Dif-
ferences in food intake or direct metabolic effects
comparing the burn and the infected burn group have not
been observed.
Peripheral blood analysis
Lymphocytes were significantly lower after 12 hours post
treatment for the burn (5000/ml ± 900; p = 0.04) and the
infected group (3000/ml ± 500; p = 0.02) compared to no
treatment control (9000/ml ± 800). No significant differ-
ences were observed for neutrophils, monocytes, red
blood cell count, platelets, hemoglobin and hematocrit
(data not shown).
Endotoxin levels
In the infected animals, endotoxin levels were signifi-
cantly higher 12 hours post treatment for the infected
burn group (625 pg/ml ± 200) compared to the burn (172
pg ± 30; p = 0.02) and control (216 pg/ml ± 48; p = 0.02)
group with no difference comparing burn only with the
control group. 24 hours post treatment no difference
between the groups was noticeable (Figure 2).
Cytokines
IL-1
Until 48 hours after thermal injury, IL-1 levels were
detected in comparable concentrations (Figure 3). After
72 hours, IL-1 concentrations in the infected group (1.125
ng/ml ± 0.19) and in the burn group (0.997 ng/ml ± 0.07)
peaked and remained significantly (p = 0.03) higher com-
pared to the no treatment control group until they
returned to baseline after 12 days.
IL-6
In the burn group and infected burn group, IL-6 concen-
trations showed a peak 48 h postburn followed by a
descend (p < 0.02) reaching baseline levels on day 6 com-
pared to no treatment control (Figure 3). No significant
difference was observed comparing the burn vs. infected
burn group.Page 3 of 7
(page number not for citation purposes)
BMC Surgery 2005, 5:19 http://www.biomedcentral.com/1471-2482/5/19IL-10
Between 24 and 72 hours postburn IL-10 levels increased sig-
nificantly in the burn and infected burn group with a steady
state after the 6th day postburn (Figure 3). No significant dif-
ference was seen comparing the burn vs. infected burn
group.
TNF-α
Levels for TNF-α were significantly higher 48 h postburn
in the infected burn group compared to the burn and no
treatment control group. The initial endotoxemia is fol-
lowed by 24 and 48 hr TNF rise which is then followed by
gradual weight loss in the infection vs. burn alone group.
After 48 hours TNF-α concentrations of the infected and
burn groups were comparable and significantly higher
compared to the control group until day 12 (p < 0,01).
Discussion
Extensive burn trauma induces an acute inflammatory
response that is associated with a variety of systemic alter-
ations including increased vascular permeability, myocar-
dial dysfunction, hypermetabolism and altered hepatic
synthetic activity [18-21].
This study demonstrates significantly higher TNF-α and
endotoxin levels associated with substantial higher weight
loss in infected burn wounds compared to non-infected
burn wounds. In the utilized animal model, weight loss
was observed for 6 days post burn in the infected group,
whereas no differences in weight loss were observed in the
non-infected burn group. However, no pair feeding was
carried out within this study in order to explain
Animal body weightFigure 1
Animal body weight. Body weight of each animal was measured every day during the whole experiment.
Weight change
240
260
280
300
320
340
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Time (days)
A
n
im
a
l
w
e
ig
h
t
(g
)
Control
Burn
Infected
*
#
#
#
+
+
# (p < 0.05 Control vs. Infected)
(p <0.05 Burn vs. Infected)*
+ (p< 0.05 Control vs. Burn)
*
#
*
#
*
#
*
#
*
#
*
#
*
#
*
# *
#
*
#Page 4 of 7
(page number not for citation purposes)
BMC Surgery 2005, 5:19 http://www.biomedcentral.com/1471-2482/5/19differences in weight gain or loss. In a clinical setting it is
impossible to investigate the reason for hypermetabolism
in burn patients [22].
Previous in vivo experiments have demonstrated higher
endotoxin levels after bacterial challenge [16,17,23,24].
Furthermore, it has been shown that cachectin and TNF is
associated with weight loss [25], which can be reversed by
blocking TNF and IL-1 receptors [26]. TNF-α is a multi-
functional cytokine that is secreted in response to injury,
inflammation or infection. In thermal injury, TNF-α is
considered a potent mediator of other cytokines such as
IL-6 [25]. Clinical and experimental studies have shown a
significant elevation in IL-6 production after burn injury
and sepsis, which correlates with suppressed cell-medi-
ated immunity and increased mortality [27-29]. In addi-
tion, blockade of IL-6 biological activity following burn
injury and/or sepsis has been shown to improve outcome
[30]. In our study we did not see any significant difference
in IL-6 production. This is due, in part, to the limited burn
area (30% BSA) without differences in mortality and
development of burn-associated immunosuppression. A
number of experimental studies have shown implication
of Th-2 cytokines, like IL-10, in immunosuppression after
thermal injury as well as in sepsis [31-33]. Recent findings
have demonstrated that the macrophages are resistant to
the suppressive effects of IL-10 post burn [34,35]. It has
been verified that block of endogenous IL-10 enhances IL-
6 and TNF-α release in response to LPS. Addition of exog-
enous IL-10 to the macrophages cultures suppresses
Endotoxin levelFigure 2
Endotoxin level. Blood serum endotoxin levels were measured 12, 24, 48, 72 h, 6 and 12 days post burn injury in infected 
and control group (each n = 6). Endotoxin amount was calculated in ng/ml serum. The values at 12 h, 6 and 12 days were fur-
ther displayed as bar graph to demonstrate significant (p < 0,05) differences.
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able to show that IL-10 expression levels were associated
with weight gain in animals with infected burn wounds.
Conclusion
We hypothesize that infection control in burned patients
is the most important factor for preventing burn-associ-
ated weight loss. Our results suggest that in the presence
of infection, you get a SIRS response possibly due to tran-
sient endotoxemia that is only seen in the infection group.
In contrast, both burn and infection get a late IL-10
(CARS) response, which is then associated with a return to
normal weight in the infection group. More studies are
clearly needed to fully understand the pathophysiology in
infected burn wounds.
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Cytokine expressionFigure 3
Cytokine expression. Blood was obtained from each rat in the separated treatment groups after 24, 48 and 72 h, 6 and 12 
days post injury. Serum was separated and analyzed for IL-1β, IL-6, IL-10 and TNF-α using ELISA detection system. A time 
course is shown including the whole follow up of the study. Amount cytokine expression is displayed in pg/ml serum.
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